TET2 Downregulation Leads to AML Cells Sensitive to Decitabine

被引：0
|
作者：
Chen, Qingxiao [1 ]
He, Jingsong [1 ]
Guo, Xing [1 ]
Chen, Jing [1 ]
Yang, Li [1 ]
Lin, Xuanru [1 ]
Li, Yi [1 ]
Zhang, Enfan [1 ]
Yang, Yang [1 ]
Wu, Wenjun [1 ]
He, Donghua [1 ]
Huang, He [1 ]
Liu, Shizhou [2 ]
Cai, Zhen [1 ]
机构：
[1] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Inst Translat Med, Hangzhou 310003, Zhejiang, Peoples R China
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [31] A novel TET2 intronic variant leads to alternative splicing in patients with myeloid neoplasm
    Cheng, Yu
    Arispe, Karen
    Zheng, Tu
    Bosler, David
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 : S55 - S55
  • [32] TET2: Is a potential gatekeeper for the action of thiazolidinedione in fat cells?
    Seo, Ji A.
    Kim, Young-Bum
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2018, 89 : A1 - A2
  • [33] Endogenous epitope-tagging of Tet1, Tet2 and Tet3 identifies TET2 as a naive pluripotency marker
    Pantier, Raphael
    Tatar, Tulin
    Colby, Douglas
    Chambers, Ian
    LIFE SCIENCE ALLIANCE, 2019, 2 (05)
  • [34] Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells
    Kunimoto, Hiroyoshi
    Fukuchi, Yumi
    Sakurai, Masatoshi
    Sadahira, Ken
    Ikeda, Yasuo
    Okamoto, Shinichiro
    Nakajima, Hideaki
    SCIENTIFIC REPORTS, 2012, 2
  • [35] Tet2 disruption leads to enhanced self-renewal and altered differentiation of fetal liver hematopoietic stem cells
    Hiroyoshi Kunimoto
    Yumi Fukuchi
    Masatoshi Sakurai
    Ken Sadahira
    Yasuo Ikeda
    Shinichiro Okamoto
    Hideaki Nakajima
    Scientific Reports, 2
  • [36] Loss of TET2 and TET3 in regulatory T cells unleashes effector function
    Yue, Xiaojing
    Lio, Chan-Wang J.
    Samaniego-Castruita, Daniela
    Li, Xiang
    Rao, Anjana
    NATURE COMMUNICATIONS, 2019, 10 (1)
  • [37] Molecular cytogenetic screening for TET2 deletions serving as example for targeted diagnostics in patients with AML
    Mohr, B.
    Stoelzel, F.
    Bornhaeuser, M.
    Ehninger, G.
    Schaich, M.
    ONKOLOGIE, 2012, 35 : 114 - 115
  • [38] High Incidence of TET2 Mutation in Chinese Patients with MDS and AML with Previous History of MDS
    Li, Lin
    Zhu Xuejun
    Jiang Pengjun
    Zhang Wenxi
    Hui, Yu
    Lin, Lin
    Chen Jianyi
    Kong Xiangtu
    Ni Haiwen
    Yu, Wu
    Xu Zuqiong
    Qun, Shen
    Ou, Ji
    Zhu Guangrong
    Yang Yueyan
    Jun, Li
    Ji Jianmin
    Sun, Xuemei
    BLOOD, 2012, 120 (21)
  • [39] Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient
    Qiang Ma
    Yixian Guo
    Xiaoxi Lan
    Guoxiang Wang
    Wanling Sun
    BMC Medical Genomics, 14
  • [40] Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient
    Ma, Qiang
    Guo, Yixian
    Lan, Xiaoxi
    Wang, Guoxiang
    Sun, Wanling
    BMC MEDICAL GENOMICS, 2021, 14 (01)
12345